Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Generation of solar spicules and subsequent atmospheric heating.

Samanta T, Tian H, Yurchyshyn V, Peter H, Cao W, Sterling A, Erdélyi R, Ahn K, Feng S, Utz D, Banerjee D, Chen Y.

Science. 2019 Nov 15;366(6467):890-894. doi: 10.1126/science.aaw2796.

2.

[Risk of second malignancies after platinum-based chemotherapy of testicular cancer].

Utz D, Müller AC.

Strahlenther Onkol. 2019 Feb;195(2):190-191. doi: 10.1007/s00066-018-1410-3. German. No abstract available.

PMID:
30564844
3.

VvGONST-A and VvGONST-B are Golgi-localised GDP-sugar transporters in grapevine (Vitis vinifera L.).

Utz D, Handford M.

Plant Sci. 2015 Feb;231:191-7. doi: 10.1016/j.plantsci.2014.11.009. Epub 2014 Dec 6.

PMID:
25576004
4.

Mating decreases plasma levels of TGFβ1 and regulates myosalpinx expression of TGFβ1/TGFBR3 in the rat.

Oróstica ML, López J, Zuñiga LM, Utz D, Díaz P, Reuquen P, Parada-Bustamante A, Cardenas H, Orihuela PA.

Mol Reprod Dev. 2014 Nov;81(11):1053-61. doi: 10.1002/mrd.22427. Epub 2014 Oct 30.

PMID:
25359088
5.

Tumour necrosis factor-α is the signal induced by mating to shutdown a 2-methoxyestradiol nongenomic action necessary to accelerate oviductal egg transport in the rat.

Oróstica ML, Zuñiga LM, Utz D, Parada-Bustamante A, Velásquez LA, Cardenas H, Orihuela PA.

Reproduction. 2013 Jan 24;145(2):109-17. doi: 10.1530/REP-12-0389. Print 2013 Feb.

PMID:
23148087
6.

Accreditation measures value.

Utz DG.

Radiol Technol. 2012 Jul-Aug;83(6):639-40. No abstract available.

PMID:
22763842
7.

Therapeutic hypothermia initiated in the pre-hospital setting: a meta-analysis.

Cullen D, Augenstine D, Kaper L, Tinkham S, Utz D.

Adv Emerg Nurs J. 2011 Oct-Dec;33(4):314-21. doi: 10.1097/TME.0b013e3182343cb6. Review.

PMID:
22075682
8.

Ligand influence over the formation of dinuclear [2+2] versus trinuclear [3+3] Cu(I) Schiff base macrocyclic complexes.

Arbuse A, Mandal S, Maji S, Martínez MA, Fontrodona X, Utz D, Heinemann FW, Kisslinger S, Schindler S, Sala X, Llobet A.

Inorg Chem. 2011 Aug 1;50(15):6878-89. doi: 10.1021/ic102185y. Epub 2011 Jul 6.

PMID:
21732585
9.

Syntheses and characterization of copper complexes with the ligand 2-aminoethyl(2-pyridylmethyl)-1,2-ethanediamine (apme).

Utz D, Kisslinger S, Hampel F, Schindler S.

J Inorg Biochem. 2008 May-Jun;102(5-6):1236-45. doi: 10.1016/j.jinorgbio.2008.01.028. Epub 2008 Feb 1.

PMID:
18329717
10.

Browning in Annona cherimola fruit: role of polyphenol oxidase and characterization of a coding sequence of the enzyme.

Prieto H, Utz D, Castro A, Aguirre C, González-Agüero M, Valdés H, Cifuentes N, Defilippi BG, Zamora P, Zúñiga G, Campos-Vargas R.

J Agric Food Chem. 2007 Oct 31;55(22):9208-18. Epub 2007 Oct 2.

PMID:
17907770
11.

Reaction behaviour of dinuclear copper(I) complexes with m-xylyl-based ligands towards dioxygen.

Foxon SP, Utz D, Astner J, Schindler S, Thaler F, Heinemann FW, Liehr G, Mukherjee J, Balamurugan V, Ghosh D, Mukherjee R.

Dalton Trans. 2004 Aug 7;(15):2321-8. Epub 2004 Jun 30.

PMID:
15278125
12.

Syntheses and characterization of two dioxygen-reactive dinuclear macrocyclic schiff-base copper(I) complexes.

Utz D, Heinemann FW, Hampel F, Richens DT, Schindler S.

Inorg Chem. 2003 Mar 10;42(5):1430-6.

PMID:
12611507
13.

Definitive therapy for prostate carcinoma: Mayo Clinic results at 15 years after treatment.

Swanson GP, Cupps RE, Utz DC, Ilstrup DM, Zincke H, Myers RP.

Br J Radiol. 1994 Sep;67(801):877-89.

PMID:
7953230
14.

Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate.

Zincke H, Utz DC, Thulé PM, Taylor WF.

Urology. 1987 Oct;30(4):307-15.

PMID:
3660520
16.

Testicular seminoma metastatic to the prostate.

Motley RC, Utz DC, Farrow GM, Earle JD.

J Urol. 1986 Apr;135(4):801-2.

PMID:
3959209
17.

Review of Mayo Clinic experience with carcinoma in situ.

Zincke H, Utz DC.

Urology. 1986 Mar;27(3):288. No abstract available.

PMID:
3082060
18.

Bladder tumors. Treated natural history.

Wolf H, Kakizoe T, Smith PH, Brosman SA, Okajima E, Rübben H, Utz DC.

Prog Clin Biol Res. 1986;221:223-55. Review. No abstract available.

PMID:
3543943
19.

Evaluation of the prostate by magnetic resonance imaging.

Larkin BT, Berquist TH, Utz DC.

Magn Reson Imaging. 1986;4(1):53-8.

PMID:
2419725
20.

Review of Mayo Clinic experience with carcinoma in situ.

Zincke H, Utz DC, Farrow GM.

Urology. 1985 Oct;26(4 Suppl):39-46.

PMID:
3931327
21.

Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic nodal disease.

Zincke H, Patterson DE, Utz DC, Benson RC Jr.

Br J Urol. 1985 Apr;57(2):156-9.

PMID:
3986450
23.

Androgen receptor binding activity in human prostate cancer.

Benson RC Jr, Utz DC, Holicky E, Veneziale CM.

Cancer. 1985 Jan 15;55(2):382-8.

PMID:
2578085
24.

Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for Stage C adenocarcinoma of prostate.

Zincke H, Utz DC, Benson RC Jr, Patterson DE.

Urology. 1984 Dec;24(6):532-9.

PMID:
6506391
26.

Epidemic of pulmonary blastomycosis (Namekagon fever) in Wisconsin canoeists.

Cockerill FR 3rd, Roberts GD, Rosenblatt JE, Utz JP, Utz DC.

Chest. 1984 Nov;86(5):688-92.

PMID:
6488903
27.

Carcinoma in situ of the urinary tract.

Utz DC, Farrow GM.

Urol Clin North Am. 1984 Nov;11(4):735-40. Review.

PMID:
6390917
28.
29.

Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma confined to the prostate.

Benson RC Jr, Tomera KM, Zincke H, Fleming TR, Utz DC.

J Urol. 1984 Jun;131(6):1103-6.

PMID:
6726908
30.

Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy.

Benson RC Jr, Kinsey JH, Cortese DA, Farrow GM, Utz DC.

J Urol. 1983 Dec;130(6):1090-5.

PMID:
6227755
31.

Radical surgery for stage D1 prostate cancer.

Zincke H, Utz DC.

Semin Urol. 1983 Nov;1(4):253-60. Review. No abstract available.

PMID:
6399611
32.

Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer.

Myers RP, Zincke H, Fleming TR, Farrow GM, Furlow WL, Utz DC.

J Urol. 1983 Jul;130(1):99-101.

PMID:
6864924
34.

Adenomatous polyp in ileal conduit.

Tomera KM, Unni KK, Utz DC.

J Urol. 1982 Nov;128(5):1025-6. No abstract available.

PMID:
7176028
35.

Invasive bladder carcinoma managed by irradiation and surgery.

DeWeerd JH, Colby MY Jr, Segura JW, Utz DC, Cupps RE.

Urology. 1982 Nov;20(5):471-5.

PMID:
7147525
36.

Percutaneous renal stone removal.

Utz DC, Smith LH.

Mayo Clin Proc. 1982 Oct;57(10):668. No abstract available.

PMID:
7121074
37.

Interstitial cystitis.

Murphy DM, Zincke H, Utz DC.

J Urol. 1982 Sep;128(3):606. No abstract available.

PMID:
7120578
38.

Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases.

Zincke H, Farrow GM, Myers RP, Benson RC Jr, Furlow WL, Utz DC.

J Urol. 1982 Sep;128(3):498-501.

PMID:
7120555
39.

Detection and localization of In situ carcinoma of the bladder with hematoporphyrin derivative.

Benson RC Jr, Farrow GM, Kinsey JH, Cortese DA, Zincke H, Utz DC.

Mayo Clin Proc. 1982 Sep;57(9):548-55.

PMID:
7109683
40.

Drug therapy of prostatic cancer.

Benson RC Jr, Utz DC, Murphy GP.

Urology. 1982 Jun;19(6):621-2. No abstract available.

PMID:
7046189
41.

Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma of prostate with regional lymph node involvement.

Zincke H, Utz DC, Myers RP, Farrow GM, Patterson DE, Furlow WL.

Urology. 1982 Mar;19(3):238-47.

PMID:
7064249
42.

Nucleolar grading of prostatic adenocarcinoma: light microscopic correlation with disease progression.

Myers RP, Neves RJ, Farrow GM, Utz DC.

Prostate. 1982;3(5):423-32.

PMID:
6183650
43.

Neurofibromatosis of the bladder in children.

Kramer SA, Barrett DM, Utz DC.

J Urol. 1981 Nov;126(5):693-4. No abstract available.

PMID:
6795365
44.

Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostate.

Zincke H, Fleming TR, Furlow WL, Myers RP, Utz DC.

Cancer. 1981 Apr 1;47(7):1901-10.

PMID:
7226084
45.

Fibrinolytic degradation products in the urine of carcinoma of the prostate patients.

Aguilo JJ, Khan AU, Bowie EJ, Utz DC, Greene LF.

Urol Int. 1981;36(1):10-4.

PMID:
7257011
46.

Definitive radiation therapy for prostatic carcinoma: Mayo clinic experience.

Cupps RE, Utz DC, Fleming TR, Carson CC, Zincke H, Myers RP.

J Urol. 1980 Dec;124(6):855-9.

PMID:
6777510
47.

Management of carcinoma in situ of the bladder: the case for surgical management.

Utz DC, Farrow GM.

Urol Clin North Am. 1980 Oct;7(3):533-41.

PMID:
7456165
48.

Radical prostatectomy after radiotherapy for prostatic cancer.

Carson CC 3rd, Zincke H, Utz DC, Cupps RE, Farrow GM.

J Urol. 1980 Aug;124(2):237-9.

PMID:
7401237
49.

Carcinoma in situ of the bladder.

Utz DC, Farrow GM, Rife CC, Segura JW, Zincke H.

Cancer. 1980 Apr 15;45(7 Suppl):1842-8. No abstract available.

PMID:
7370935
50.

Carcinoma in Situ of the Bladder.

Utz DC, Farrow GM, Rife CC, Segura JW, Zincke H.

Cancer. 1980 Apr;45 Suppl 7:1842-1848. doi: 10.1002/cncr.1980.45.s7.1842.

PMID:
29603178

Supplemental Content

Support Center